Entrectinib—A SARS-CoV-2 Inhibitor in Human Lung Tissue (HLT) Cells
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Since the start of the COVID-19 outbreak, pharmaceutical companies and research groups have focused on the development of vaccines and antiviral drugs against SARS-CoV-2. Here, we apply a drug repurposing strategy to identify drug candidates that are able to block the entrance of the virus into human cells. By combining virtual screening with in vitro pseudovirus assays and antiviral assays in Human Lung Tissue (HLT) cells, we identify entrectinib as a potential antiviral drug.
Article activity feed
-
-
SciScore for 10.1101/2021.09.07.459123: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Antibodies Sentences Resources On Day 3, cells were incubated with 20ul of 6x concentrations in HBSS of either the small molecules/peptides or an anti ACE2 antibody (AG-20A-0037PF-C500, Adipogen) for three hours. anti ACE2suggested: NoneExperimental Models: Cell Lines Sentences Resources Top hits were analyzed using VMD 1.9.3 software [30]. 4.4. Plasmids & Cell lines: The Lenti X 293T cell line (632180) was purchased from Takara Bio. X 293Tsuggested: NonePseudovirus production: On Day 1, Lenti X 293T cells were seeded at a density of 60,000 cells/cm2 per T175 flask in 34ml DMEM supplemented with 10% FBS and 1mM Sodium Pyruvate. Lenti X …SciScore for 10.1101/2021.09.07.459123: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Antibodies Sentences Resources On Day 3, cells were incubated with 20ul of 6x concentrations in HBSS of either the small molecules/peptides or an anti ACE2 antibody (AG-20A-0037PF-C500, Adipogen) for three hours. anti ACE2suggested: NoneExperimental Models: Cell Lines Sentences Resources Top hits were analyzed using VMD 1.9.3 software [30]. 4.4. Plasmids & Cell lines: The Lenti X 293T cell line (632180) was purchased from Takara Bio. X 293Tsuggested: NonePseudovirus production: On Day 1, Lenti X 293T cells were seeded at a density of 60,000 cells/cm2 per T175 flask in 34ml DMEM supplemented with 10% FBS and 1mM Sodium Pyruvate. Lenti X 293Tsuggested: NonePseudovirus assay: On Day 1, 293T cells were seeded at 30,000 per well in white solid bottom 96 well plates that were either Poly L Lysine or Collagen coated in completed media (DMEM + 10% FBS + 1mM Sodium Pyruvate) at 37°C and 5% CO2. 293Tsuggested: NoneRecombinant DNA Sentences Resources pLenti CMV Puro Luc (17477), pMDLg.pRRE (12251), pRSV. pMDLg.pRREsuggested: NoneREV (12253), pMD2.G (12259) were purchased from Addgene. pMD2 . Gsuggested: NoneThe Spike ORF was subcloned into pcDNA3.1(+) vector via Gibson Assembly (NEB). pcDNA3.1 ( + )suggested: NoneΔ Spike: 20μg pLenti Luc, 20μg pMDLg.pRRE, 9.5μg pRSV. pRSVsuggested: RRID:Addgene_106453)Firefly Luciferase, encoded by pLenti Luc was used as the assay reporter. VSV.G, encoded by pMD2. pMD2suggested: NoneSoftware and Algorithms Sentences Resources For this purpose, DrugBank [ DrugBanksuggested: (DrugBank, RRID:SCR_002700)22] and PubChem [23] databases were used, merging both of them in a single database in SDF format. PubChemsuggested: (PubChem, RRID:SCR_004284)Then, different conformations for each compound were found using LigPrep software [27]. LigPrepsuggested: (Ligprep, RRID:SCR_016746)4.3 Molecular Docking: For the molecular docking, AutoDock Vina 1.1.2 software [25,26] was used. AutoDocksuggested: (AutoDock, RRID:SCR_012746)Data was analysed on GraphPad Prism software. GraphPad Prismsuggested: (GraphPad Prism, RRID:SCR_002798)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We found bar graphs of continuous data. We recommend replacing bar graphs with more informative graphics, as many different datasets can lead to the same bar graph. The actual data may suggest different conclusions from the summary statistics. For more information, please see Weissgerber et al (2015).
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
Results from scite Reference Check: We found no unreliable references.
-